MedTrace Logo

Spinal Cord Injury Virtual Coach RCT

NCT02876666 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2017-07-28

No results posted yet for this study

Summary

The SCI Virtual Coach study has developed an on-screen, human-like character that will provide support, education and coaching to adults with spinal cord injury (SCI) to aid in the prevention of serious secondary conditions like pressure ulcers. In a randomized controlled trial, participants assigned to "the Coach" intervention will have a touch-screen computer placed in their homes and be asked to interact with the Coach on a daily basis for 2 months. Participants will be asked to complete surveys at baseline and 2 months.

The SCI Virtual Coach study aims to measure how accessible and usable participants feel the Coach is, as well as participants' adherence to the Coach's instructions. It will also gauge how effective the Coach is in changing self-care knowledge, health care behaviors, self-efficacy for self-care, and perception of social support in participants.

Conditions

  • Spinal Cord Injuries

Interventions

BEHAVIORAL

SCI Virtual Coach

Participants are given a computer with the SCI Virtual Coach program and are asked to interact with the Coach daily for 2 months.

Sponsors & Collaborators

  • The Craig H. Neilsen Foundation

    collaborator OTHER

  • Northeastern University

    collaborator OTHER

  • Boston University

    lead OTHER

Principal Investigators

  • Nancy Latham, PT, PhD · Boston University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2017-06-30
Completion
2017-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02876666 on ClinicalTrials.gov